Edgar Braendle

408 total citations
10 papers, 321 citations indexed

About

Edgar Braendle is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Edgar Braendle has authored 10 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Pathology and Forensic Medicine and 3 papers in Oncology. Recurrent topics in Edgar Braendle's work include Bone health and treatments (2 papers), Cancer Mechanisms and Therapy (2 papers) and Peptidase Inhibition and Analysis (2 papers). Edgar Braendle is often cited by papers focused on Bone health and treatments (2 papers), Cancer Mechanisms and Therapy (2 papers) and Peptidase Inhibition and Analysis (2 papers). Edgar Braendle collaborates with scholars based in United States, Germany and Switzerland. Edgar Braendle's co-authors include Maren Mieth, Jessica Rademacher, Martin Kaiser, Ulrike Heider, Orhan Sezer, Christian Jakob, David R. Stover, Malte Peters, Lorenz Kleeberg and Claudia Fleissner and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.

In The Last Decade

Edgar Braendle

9 papers receiving 320 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Edgar Braendle United States	5	179	160	100	50	29	10	321
Nazir Jamal Canada	6	92 0.5×	101 0.6×	74 0.7×	65 1.3×	23 0.8×	9	270
Amanda Goldrick Australia	8	83 0.5×	166 1.0×	38 0.4×	46 0.9×	29 1.0×	11	245
Carolyn H. Condon United States	3	241 1.3×	74 0.5×	83 0.8×	33 0.7×	21 0.7×	6	366
Benjamin J. Gigliotti United States	7	106 0.6×	188 1.2×	77 0.8×	93 1.9×	34 1.2×	18	392
Krinio Giannikou United States	12	189 1.1×	101 0.6×	76 0.8×	123 2.5×	30 1.0×	23	459
Theresa Kapral Austria	7	193 1.1×	99 0.6×	60 0.6×	32 0.6×	43 1.5×	8	405
Amelia E. Pearsall United States	5	296 1.7×	97 0.6×	174 1.7×	39 0.8×	23 0.8×	7	506
Vlastimil Ščudla Czechia	11	144 0.8×	117 0.7×	177 1.8×	12 0.2×	7 0.2×	42	265
Lu Wen China	12	89 0.5×	105 0.7×	35 0.3×	37 0.7×	43 1.5×	27	329
M. Maasberg Germany	8	139 0.8×	104 0.7×	44 0.4×	52 1.0×	34 1.2×	15	330

Countries citing papers authored by Edgar Braendle

Since Specialization

Citations

This map shows the geographic impact of Edgar Braendle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edgar Braendle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edgar Braendle more than expected).

Fields of papers citing papers by Edgar Braendle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edgar Braendle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edgar Braendle. The network helps show where Edgar Braendle may publish in the future.

Co-authorship network of co-authors of Edgar Braendle

This figure shows the co-authorship network connecting the top 25 collaborators of Edgar Braendle. A scholar is included among the top collaborators of Edgar Braendle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edgar Braendle. Edgar Braendle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Roeland, Eric, Mohamedtaki Abdulaziz Tejani, Eric Cheung, et al.. (2025). A phase 1b dose escalation study of AV-380 (anti-GDF15 monoclonal antibody) in combination with standard-of-care therapy in cancer patients with cachexia.. Journal of Clinical Oncology. 43(16_suppl).

Lebedinsky, Claudia, Stephen P. Anthony, Golam Mohi, et al.. (2020). A Phase 1 Study of TP-3654, an Orally-Delivered PIM Kinase Inhibitor, in Patients with Intermediate-2 or High-Risk Primary or Secondary Myelofibrosis. Blood. 136(Supplement 1). 3–4. 2 indexed citations

Braendle, Edgar, et al.. (2020). A phase Ib/II, multicenter, open-label study of DSP-7888 dosing emulsion in combination with immune checkpoint inhibitors (CPI) nivolumab or pembrolizumab in adult patients (pts) with advanced solid tumors, including platinum-resistant ovarian cancer (PROC).. Journal of Clinical Oncology. 38(15_suppl). TPS6099–TPS6099. 2 indexed citations

Kaiser, Martin, Maren Mieth, Peter Liebisch, et al.. (2008). Serum concentrations of DKK‐1 correlate with the extent of bone disease in patients with multiple myeloma. European Journal Of Haematology. 80(6). 490–494. 124 indexed citations

Heider, Ulrike, Martin Kaiser, Maren Mieth, et al.. (2008). Serum concentrations of DKK‐1 decrease in patients with multiple myeloma responding to anti‐myeloma treatment. European Journal Of Haematology. 82(1). 31–38. 53 indexed citations

Sarker, Debashis, R. Molife, T. R. J. Evans, et al.. (2008). A Phase I Pharmacokinetic and Pharmacodynamic Study of TKI258, an Oral, Multitargeted Receptor Tyrosine Kinase Inhibitor in Patients with Advanced Solid Tumors. Clinical Cancer Research. 14(7). 2075–2081. 117 indexed citations

Leitzel, Kim, Seth A. Ettenberg, Robert J. Walsh, et al.. (2007). Elevated serum M-CSF level predicts reduced survival in metastatic breast cancer patients. Journal of Clinical Oncology. 25(18_suppl). 10591–10591. 4 indexed citations

Rinnab, L., Michael Straub, Richard E. Hautmann, & Edgar Braendle. (2005). Postoperative resorptive and excretory capacity of the ileal neobladder. British Journal of Urology. 95(9). 1289–1292. 15 indexed citations

Straub, Michael, et al.. (2003). The impact of carbonic anhydrase on the regulation of transcellular oxalate transport in the proximal tubule. European Urology Supplements. 2(1). 78–78. 1 indexed citations

10.

Braendle, Edgar, Jochen Kindler, & H. G. Sieberth. (1990). Effects of an Acute Protein Load in Comparison to an Acute Load of Essential Amino Acids on Glomerular Filtration Rate, Renal Plasma Flow, Urinary Albumin Excretion and Nitrogen Excretion. Nephrology Dialysis Transplantation. 5(8). 572–578. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact